FGF14 IS A FUNCTIONAL TUMOR SUPPRESSOR THROUGH INHIBITING PI3K/AKT/MTOR PATHWAY IN COLORECTAL CANCER

被引:1
|
作者
Su, Tianhong [1 ]
Zhang, Ning [1 ]
Huang, Linlin [1 ]
Wei, Guangyan [1 ]
Peng, Sui [1 ]
Zeng, Zhirong [1 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China
关键词
D O I
10.1136/gutjnl-2019-IDDFabstracts.28
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
IDDF2019-A
引用
收藏
页码:A15 / A15
页数:1
相关论文
共 50 条
  • [31] Tocopherol attenuates the oxidative stress of BMSCs by inhibiting ferroptosis through the PI3k/AKT/mTOR pathway
    Lan, Dongmei
    Yao, Chao
    Li, Xue
    Liu, Haijiang
    Wang, Dan
    Wang, Yan
    Qi, Shengcai
    [J]. FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2022, 10
  • [32] EFFECTS OF SULFORAPHANE ON APOPTOSIS AND PI3K/AKT/MTOR PHOSPHORYLATION PATHWAY IN COLORECTAL CANCER CELLS
    Jiang, Yuanxue
    Kuang, Meiling
    Deng, Caijiu
    [J]. ACTA MEDICA MEDITERRANEA, 2022, 38 (01): : 227 - 231
  • [33] To Investigate the Occurrence and Development of Colorectal Cancer Based on the PI3K/AKT/mTOR Signaling Pathway
    Zhong, Jiateng
    Ding, Shuang
    Zhang, Xinyu
    Di, Wenyu
    Wang, Xiaohui
    Zhang, Hui
    Chen, Yiyang
    Zhang, Yongxi
    Hu, Yuhan
    [J]. FRONTIERS IN BIOSCIENCE-LANDMARK, 2023, 28 (02):
  • [34] Salidroside induces apoptosis and autophagy in human colorectal cancer cells through inhibition of PI3K/Akt/mTOR pathway
    Fan, Xiang-Jun
    Wang, Yao
    Wang, Lei
    Zhu, Mingyan
    [J]. ONCOLOGY REPORTS, 2016, 36 (06) : 3559 - 3567
  • [35] Targeting PI3K/AKT/mTOR Signaling Pathway in Breast Cancer
    Li, Huayi
    Prever, Lorenzo
    Hirsch, Emilio
    Gulluni, Federico
    [J]. CANCERS, 2021, 13 (14)
  • [36] EHMT2 promotes the development of prostate cancer by inhibiting PI3K/AKT/mTOR pathway
    Fan, H-T
    Shi, Y-Y
    Lin, Y.
    Yang, X-P
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (18) : 7808 - 7815
  • [37] High glucose inhibits autophagy and promotes the proliferation and metastasis of colorectal cancer through the PI3K/AKT/mTOR pathway
    Li, Feng
    Wan, Xing
    Li, Zhigui
    Zhou, Liming
    [J]. CANCER MEDICINE, 2024, 13 (11):
  • [38] The PI3K/AKT/mTOR Pathway as a Therapeutic Target in Endometrial Cancer
    Slomovitz, Brian M.
    Coleman, Robert L.
    [J]. CLINICAL CANCER RESEARCH, 2012, 18 (21) : 5856 - 5864
  • [39] Prospects of targeting PI3K/AKT/mTOR pathway in pancreatic cancer
    Mortazavi, Motahareh
    Moosavi, Fatemeh
    Martini, Miriam
    Giovannetti, Elisa
    Firuzi, Omidreza
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022, 176
  • [40] Targeting the PI3K/Akt/mTOR Pathway for Breast Cancer Therapy
    Cidado, Justin
    Park, Ben Ho
    [J]. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2012, 17 (3-4) : 205 - 216